David G. Nathan
David G. Nathan (pronounced DAY-vid G. NAY-thun) is a prominent American pediatrician and hematologist. He is best known for his work in the field of Pediatric Hematology and Oncology, particularly in the treatment of Sickle Cell Disease and Thalassemia.
Etymology
The name David is of Hebrew origin, meaning "beloved". The middle initial G stands for "Gerald", an English name meaning "rule of the spear". Nathan is a Hebrew name meaning "he gave".
Career
David G. Nathan began his career at the Boston Children's Hospital, where he served as the Physician-in-Chief from 1985 to 1995. He was also the President of the Dana-Farber Cancer Institute from 1995 to 2000. Nathan is known for his pioneering work in developing treatments for blood disorders in children, particularly sickle cell disease and thalassemia.
Contributions to Medicine
Nathan's most significant contribution to medicine is his work on the treatment of sickle cell disease. He was instrumental in developing Hydroxyurea, a drug that reduces the frequency of painful crises and acute chest syndrome in adults with sickle cell disease. He also made significant contributions to the treatment of thalassemia, a group of inherited blood disorders.
Related Terms
- Pediatric Hematology: The branch of medicine concerned with the study of the cause, diagnosis, treatment, and prevention of diseases related to blood in children.
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Sickle Cell Disease: A group of disorders that cause red blood cells to become misshapen and break down.
- Thalassemia: An inherited blood disorder characterized by less hemoglobin and fewer red blood cells in your body than normal.
- Hydroxyurea: A medication used in sickle-cell disease to decrease the number of painful crises.
External links
- Medical encyclopedia article on David G. Nathan
- Wikipedia's article - David G. Nathan
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski